Red cell distribution width, a predictive factor in immunocompromised patients with COVID-19: A comparison

Minoosh Moghimi1, Manijeh Jozpanahi2, Kasra Khodadadi3

  • 1Department of Internal Medicine, Zanjan University of Medical Sciences, Zanjan. mmoghimi2000@yahoo.com.

Insights

Lactate dehydrogenase (LDH) was the sole predictor of death in COVID-19 patients. Active cancer patients showed higher red cell distribution width (RDW), indicating more severe disease.

Area of Science:

  • Oncology
  • Nephrology
  • Infectious Diseases

Background:

  • COVID-19 presents unique challenges for immunocompromised patients, including those with cancer or kidney transplants.
  • Understanding disease outcomes in these vulnerable populations is crucial for effective management.

Purpose of the Study:

  • To compare COVID-19 outcomes in cancer and kidney transplant patients.
  • To identify predictors of mortality and ICU admission in these cohorts.

Main Methods:

  • Single-center, historical cohort study of 1135 COVID-19 patients.
  • Patients with cancer (active and non-active) and kidney transplants were analyzed.
  • Disease outcomes, including mortality and ICU admission, were compared between subgroups.

Main Results:

  • Lactate dehydrogenase (LDH) was the only significant predictor of death.
  • Red cell distribution width (RDW) was significantly higher in active cancer patients compared to kidney transplant patients.
  • Female sex and low oxygen saturation (SpO2) increased the likelihood of ICU admission.
  • No significant difference in mortality was observed between active and non-active cancer groups.

Conclusions:

  • Active cancer patients generally experience more severe and complicated COVID-19.
  • RDW may serve as a potential predictive marker for disease severity in cancer patients with COVID-19.
  • LDH is a key prognostic indicator for mortality in this patient population.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
58
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
490
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
80